Status:
COMPLETED
Tailored Case Management for Diabetes and Hypertension
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Diabetes
Hypertension
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Diabetes and hypertension co-exist in approximately 10 million people in the USA and constitute severe risk factors for the development of such complications as heart and kidney disease. The investiga...
Eligibility Criteria
Inclusion
- Enrolled and receiving primary care at one of 9 participating clinics in North Carolina
- Diagnosis of diabetes as determined by billing data
- Taking medication for diabetes
- Diagnosis of hypertension as determined by billing data
- Taking medication for hypertension
- Most recent (within one year) Hemoglobin A1c \>= 7.5%
Exclusion
- Active psychosis
- Hospitalization for stroke, myocardial infarction (MI), or coronary artery revascularization in the past 6 months
- Type I diabetes
- Does not speak English
- No access to a telephone
- Institution-dwelling or receiving comprehensive professional home health care
- Hearing or speech inadequate for long interactive phone conversations
- Terminal illness or active treatment for cancer
- Cognitive impairment too severe to understand instructions
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
377 Patients enrolled
Trial Details
Trial ID
NCT00978835
Start Date
May 1 2008
End Date
July 1 2013
Last Update
July 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27705